Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.56 | 0.04 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.04 |
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |